NCT00754715View on ClinicalTrials.gov

Study to Assess Safety, Tolerability and Pharmacokinetics After Single Doses of AZD2516 to Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

November 30, 2008

Study Completion Date

December 31, 2008

Conditions
Healthy
Interventions
DRUG

AZD2516

Solution administered once orally

DRUG

Placebo

Solution administered only once

Trial Locations (1)

Unknown

Research Site, Stockholm

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY